Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme
Alena Moerman(Ghent University Hospital), Elizaveta Padalko(Ghent University Hospital), Barbara Dujardin(Centre Hospitalier Universitaire de Tivoli), Joachim Mariën(University of Antwerp), Dorien Van den Bossche(Instituut voor Tropische Geneeskunde), Marijke Reynders, Kevin K. Ariën(University of Antwerp), Arnaud Capron(Sciensano (Belgium)), An Boel, Kris Vernelen(Sciensano (Belgium)), Natasja Van Gasse(Antwerp University Hospital), Jos Van Acker(Sciensano (Belgium)), Bernard China(Sciensano (Belgium)), Marie‐Luce Delforge(Université Libre de Bruxelles), Sara Vijgen(Jessa Hospital), Melissa Depypere(KU Leuven), Jonathan Brauner(Centre Hospitalier Universitaire de Tivoli)
Cited by 2
Related Papers
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium
|JAMA|2020|352
Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium
|Nature Medicine|2022|270
Invasive aspergillosis in patients with severe alcoholic hepatitis
|Journal of Hepatology|2013|149
Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts
|Frontiers in Pediatrics|2020|113